Scientists at Yale University have developed a device that can restore circulation and cellular activity in a pig’s brain four hours after death, raising ethical questions about the possibilities of one day applying it to humans. BrainEx is an open-source device originally based on CaVESWave, a system developed by Biomed Innovations of North Carolina to preserve donated organs for […]
A test that measures the RNA or protein molecules in human cells is also able to detect when your body is fighting a viral infection from respiratory symptoms, according to Yale researchers. The test involves a nasal swab and could be a faster and cheaper way to diagnose respiratory viral illnesses. “It’s a simpler test […]
(Reuters) — The number of U.S. diabetics with healthy blood sugar levels has declined in recent years, a study suggests. Researchers analyzed data on 1.6 million adults with diabetes from 2006 to 2013. During this period, the proportion with HbA1c below 7% declined from 56% to 54%, and the share with HbA1c at or above 9% […]
MASSDEVICE ON CALL — A new imaging tool could help cardiologists better determine which patients are at the highest risk of sudden cardiac arrest and would most likely benefit from receiving an implanted cardioverter defibrillator, according to researchers at the University of Buffalo.
The researchers reported the findings of the UB Parapet study, touted as the largest PET study imaging study ever done on cardiac arrest, at this year’s Heart Rhythm Society meeting.
MASSDEVICE ON CALL — Medistem Inc. (PINK:MEDS) partnered with Yale University on diabetes treatment using stem cells to generate pancreatic islets from endometrial regenerative cells.
Pancreatic islets effectively treated diabetes in animal models, and Medistem is also studying ERCs as therapy for critical limb ischemia and congestive heart failure, both complications of uncontrolled diabetes.
Medtronic (NYSE:MDT) revealed that California attorney general Kamala Harris wants it to cough up documents on its controversial Infuse bone growth protein.
Its the latest in a line of subpoenas dating back to October 2008, when Massachusetts AG Martha Coakley requested documents related to Infuse.
A Yale School of Medicine probe into the clinical data behind Medtronic’s (NYSE:MDT) Infuse bone protein will feature independent reviews by separate research teams in Oregon and the U.K.
MASSDEVICE ON CALL —Medtronic’s (NYSE:MDT) controversial bone growth protein Infuse will get the Yale treatment as the university’s rock-star scientist Dr. Harlan Krumholz prepares to determine whether Infuse is safe and effective.
Riding on a wave of accusations against the company and researchers on its payroll, Medtronic paid Yale University $2.5 million to conduct an independent study of the Infuse orthobiologic protein, which is used in spinal surgeries.
MASSDEVICE ON CALL — Heart patients who receive drug-eluting stents have a lower likelihood of suffering a heart attack or blockage in the vessel downstream from the stent, according to researchers at Cleveland Clinic.
The research suggests that the drug coating on the stents may bring medicine to vessels beyond the area targeted by the DES.
Medtronic Inc. (NYSE:MDT) announced Wednesday that it is offering a $2.5 million grant to Yale researchers who will independently review the safety of the company’s controversial Infuse bone graft product.
The funds will cover two reviews of the so-called recombinant bone morphogenic protein-2 (rhBMP-2) product, which stimulates bone formation. Yale expects to complete the reviews in six months.